BPG is committed to discovery and dissemination of knowledge
Featured Articles
8/26/2019 8:57:33 AM | Browse: 106 | Download: 95
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 46646
Country of Manuscript Source Japan
2019-02-20 07:29
Peer-Review Started
2019-02-22 09:02
To Make the First Decision
2019-04-16 06:31
Return for Revision
2019-04-17 08:52
2019-04-17 12:35
Second Decision
2019-05-27 08:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-05-29 17:48
Articles in Press
2019-05-29 17:48
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2019-07-15 07:57
Publish the Manuscript Online
2019-07-15 10:30
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Oncology
Manuscript Type Minireviews
Article Title Recent progress of chemotherapy and biomarkers for gastroesophageal cancer
Manuscript Source Invited Manuscript
All Author List Osamu Maeda and Yuichi Ando
Funding Agency and Grant Number
Corresponding author Osamu Maeda, MD, PhD, Lecturer, Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan. maeda-o@med.nagoya-u.ac.jp
Keywords Gastroesophageal cancer; Chemotherapy; Biomarker; HER2
Core Tip This article reviewed the current status and recent developments of gastroesophageal cancer and its related biomarkers for treatment selection. Platinum, fluoropyrimidines, taxanes, irinotecan, trastuzumab and ramucirumab are key drugs. Recently, anti-PD-1 antibodies have become available. PD-L1 expression and microsatellite instability are used to predict the effectiveness of immunotherapy. Genome-wide analysis will provide a better understanding of the biology in gastroesophageal cancer.
Publish Date 2019-07-15 10:30
Citation Maeda O, Ando Y. Recent progress of chemotherapy and biomarkers for gastroesophageal cancer. World J Gastrointest Oncol 2019; 11(7): 518-526
Url https://www.wjgnet.com/1948-5204/full/v11/i7/518.htm
DOI https://dx.doi.org/10.4251/wjgo.v11.i7.518
Full Article (PDF) WJGO-11-518.pdf
Full Article (Word) WJGO-11-518.docx
Manuscript File 46646-Review.docx
Answering Reviewers 46646-Answering reviewers.pdf
Audio Core Tip 46646-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 46646-Conflict-of-interest statement.pdf
Copyright License Agreement 46646-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 46646-Language certificate.pdf
Peer-review Report 46646-Peer-review(s).pdf
Scientific Misconduct Check 46646-Scientific misconduct check.pdf
Scientific Editor Work List 46646-Scientific editor work list.pdf